Cilcare's CIL001 Targets Cochlear Synaptopathy — An American/French Collaboration

'Cilcare expands its collaboration network to accelerate revolutionary treatment for cochlear synaptopathy with new clinical trial and biomarker innovation'

CIL001 is focusing on cochlear 'synaptopathy' — oh dear. Bad memories.

Cilcare's main website lists four products.

People may want to dig in to find out more...

 

Excerpt from a recent article on the New Scientist:

 

@Fields, that's a good find, along with Rinri Therapeutics, which uses stem cells to proliferate into auditory nerve cells. This is, though, distinct from synapses.

 

Imagine we could take a pill and repair these nerves!

 

I personally thought this was a little funny:

Imagine going from hearing loss and tinnitus on one end of the scale to not being able to sleep because of the crying baby three doors down the street on the other.

UNLIMITED SYNAPSES!

 

I'd take it even if it was a suppository!

 

You don't have to imagine if you have hyperacusis, lol.

 

Superior hearing would be like higher frequency range... it could create issues with some stuff. I'd gladly take this over tinnitus and fragile ears.

Suppository would be so awesome! Like, hey my hearing turn to shit... but now we can use the asshole to fix it.

 

Hopefully, increased hearing would turn down the brain's central gain and reduce hyperacusis.

My tinnitus sucks, but my hyperacusis is horrible.

 

It looks like Cilcare licensed Paliroden and Xaliproden.

→ 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases